InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Christopher Richard Anzalone, Chief Executive Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 27 open-market SEC Form 4 transactions: 0 purchases worth $0 and 27 sales worth $38.3M, reported from Oct 20, 21 to Jan 2, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 26 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 7.4K | $66.39 | $489K |
| Dec 29, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 35.2K | $69.33 | $2.4M |
| Dec 22, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 10.0K | $68.85 | $684K |
| Dec 19, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 8.1K | $68.48 | $554K |
| Dec 17, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 46.3K | $66.30 | $2.9M |
| Dec 16, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 14.1K | $67.87 | $876K |
| Dec 15, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 100.5K | $69.96 | $6.9M |
| Apr 11, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 50.8K | $11.49 | $584K |
| Apr 10, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 50.0K | $10.87 | $544K |
| Apr 9, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 35.3K | $11.76 | $351K |
| Mar 13, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 51.4K | $15.07 | $775K |
| Mar 4, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 133.3K | $17.02 | $2.3M |
| Mar 3, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 166.7K | $18.03 | $3.0M |
| Jan 2, 25 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 11.5K | $19.05 | $219K |
| Dec 23, 24 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 12.6K | $19.59 | $246K |
| Dec 18, 24 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 12.7K | $22.12 | $260K |
| Jan 31, 24 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 37.8K | $32.71 | $1.2M |
| Jan 2, 24 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 5.3K | $31.25 | $166K |
| Dec 20, 23 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 12.0K | $28.54 | $342K |
| Oct 25, 23 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 24.3K | $24.21 | $589K |
| Sep 18, 23 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 31.5K | $28.27 | $883K |
| May 4, 23 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 26.0K | $40.02 | $1.0M |
| May 3, 23 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 54.9K | $39.14 | $2.1M |
| Feb 11, 22 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 61.5K | $53.11 | $3.1M |
| Dec 15, 21 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 25.9K | $70.19 | $1.7M |
| Oct 22, 21 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 44.2K | $66.09 | $2.9M |
| Oct 20, 21 | ARWRARROWHEAD PHARMACEUTICALS, INC. | SELL | 15.0K | $66.23 | $993K |